Genitourinary (GU) ASCO 2022 Highlights with Dr. Shilpa Gupta

(39)-1

Discussing Genitourinary (GU) Cancers ASCO 2022

Practice changing studies with Dr. Shilpa Gupta, Director of Taussig Cancer Institute and Co-Leader GU Onc, Cleveland Clinic GU Malignancy.

Tags: Dr. Shilpa Gupta (GU) ASCO 2022 Genitourinary

Conferences ASCO 2024

GI Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Mark Lewis

Aug 24, 2024

Conferences ASCO 2024

GU Cancer ASCO 2024 Practice Changing Highlights - Discussion with Dr. Toni Choueiri

Aug 24, 2024